scholarly journals COVID-19 vaccine willingness among patients with mental illness compared with the general population – CORRIGENDUM

2022 ◽  
pp. 1-1
Author(s):  
Oskar Hougaard Jefsen ◽  
Pernille Kølbæk ◽  
Yael Gil ◽  
Maria Speed ◽  
Peter Thisted Dinesen ◽  
...  
Keyword(s):  
Mental Illness ◽  
General Population

Overcoming the Complexities of Mental Illness and Homelessness

2014 ◽  
Vol 1 (1) ◽  
Author(s):  
Chelsea Lee Dost
Keyword(s):  
Mental Illness ◽  
Social Work ◽  
General Population ◽  
Continuity Of Care ◽  
Contributing Factors ◽  
The Many

Mental illness and homelessness are inextricably tied together in a way that has created a costly problem which profoundly affects both individuals and society. To begin to eradicate this problem, the severity and complexity must be understood by considering the many contributing factors to both mental illness and homelessness. Care must be individualized to fit each person’s unique situation, and continuity of care is absolutely critical. This problem has ramifications for many disciplines such as healthcare, social work, corrections, and housing, but stigma in the general population must also be addressed if progress is to be made.

Student nurses and the general population in Sweden: Trends in attitudes towards mental illness

2012 ◽  
Vol 67 (3) ◽  
pp. 164-170 ◽  
Author(s):  
Béatrice Ewalds-Kvist ◽  
Torbjörn Högberg ◽  
Kim Lützén
Keyword(s):  
Mental Illness ◽  
General Population ◽  
Student Nurses

scholarly journals Oral health inequality in people with severe mental illness: a cross-sectional study using National Health and Nutrition Examination Survey 1999-2016

2021 ◽  
Author(s):  
Jing Kang ◽  
Jianhua Wu ◽  
Vishal Aggarwal ◽  
David Shiers ◽  
Tim Doran ◽  
...  
Keyword(s):  
Risk Factors ◽  
Mental Illness ◽  
Oral Health ◽  
General Population ◽  
Health Outcomes ◽  
Severe Mental Illness ◽  
Tooth Loss ◽  
List Type ◽  
Cross Sectional ◽  
Oral Health Outcomes

AbstractOBJECTIVETo explore whether people with severe mental illness (SMI) experience worse oral health compared to the general population, and the risk factors for poor oral health in people with SMI.METHODThis study used cross-sectional data from the National Health and Nutrition Examination Survey (1999-2016) including on self-rated oral health, ache in mouth, tooth loss, periodontitis stage, and number of decayed, missing, and filled teeth. Candidate risk factors for poor oral health included demographic characteristics, lifestyle factors, physical health comorbidities, and dental hygiene behaviours. The authors used ordinal logistic regression and zero-inflated negative binomial models to explore predictors of oral health outcomes.RESULTS53,348 cases were included in the analysis, including 718 people with SMI. In the fully adjusted model, people with SMI were more likely to suffer from tooth loss (OR 1.40, 95% CI: 1.12-1.75). In people with SMI, the risk factors identified for poor oral health outcomes were older age, white ethnicity, lower income, smoking history, and diabetes. Engaging in physical activity and daily use of dental floss were associated with better oral health outcomes.CONCLUSIONSPeople with SMI experience higher rates of tooth loss than the general population, and certain subgroups are particularly at risk. Having a healthy lifestyle such as performing regular physical exercise and flossing may lower the risk of poor oral health. These findings suggest opportunities for targeted prevention and early intervention strategies to mitigate adverse oral health outcomes.Significant outcomes (x3)People with severe mental illness were at 40% higher risk of tooth loss when compared to the general population.Older adults, smokers and people with diabetes were at particularly high risk of poor oral health.Physical exercise and daily use of dental floss were associated with better oral health outcomes.Limitations (x3)The number of cases with data on periodontal disease was limited.The study was cross-sectional so causation could not be inferred.The analysis used prescriptions of antipsychotic and mood stabilising medication as a proxy measure of severe mental illness, as clinical diagnoses were not available in the dataset.Data availability statementThe NHANES 1999-2016 data is available at CDC website: https://www.cdc.gov/nchs/nhanes/index.htm, and is accessible and free to download for everyone.

scholarly journals Prevalence and determinants of tobacco use amongst South African adults with mental illness in the Eastern Cape

2021 ◽  
Vol 27 ◽  
Author(s):  
Linda K. Tindimwebwa ◽  
Anthony I. Ajayi ◽  
Oladele V. Adeniyi
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
General Population ◽  
Tobacco Use ◽  
Depressive Disorders ◽  
Smoking Prevention ◽  
Eastern Cape ◽  
Physical And Mental Health ◽  
Cross Sectional ◽  
Tobacco Products

Background: Given the physical and mental health consequences of tobacco use amongst individuals with mental illness, it was imperative to assess the burden of tobacco use in this population.Aim: This study examined the patterns and factors associated with tobacco use in individuals attending the outpatient unit.Setting: Cecilia Makiwane Hospital Mental Health Department in Eastern Cape province, South Africa.Methods: Lifetime (ever use) use and current use of any tobacco products were examined in a cross-sectional study of 390 individuals between March and June 2020. A logistic regression was fitted to determine the correlates of lifetime and current use of any tobacco products.Results: The rates of ever use and current use of tobacco products were 59.4% and 44.6%, respectively. Of the participants interviewed, lifetime tobacco use was more prevalent amongst individuals with schizophrenia (67.9%) and cannabis-induced disorders (97.3%) and lower in those with major depressive disorders (36.1%) and bipolar and related disorders (43.5%). Men were six times more likely to have ever used or currently use tobacco products in comparison to women. Also, those who had a salaried job or owned a business were over three times more likely to have ever used or currently use tobacco products compared with those receiving government social grants.Conclusions: The prevalence of tobacco use in this study was significantly higher than the general population in the Eastern Cape. Therefore, smoking prevention and cessation interventions targeted at the general population should target this often neglected sub-population in the region.

scholarly journals Lifestyle behaviors among 4,343 Brazilian adults with severe mental illness and 55,859 general population controls: data from the Brazilian National Health Survey

2020 ◽  
Vol 42 (3) ◽  
pp. 245-249 ◽  
Author(s):  
André O. Werneck ◽  
Davy Vancampfort ◽  
Adewale L. Oyeyemi ◽  
Célia L. Szwarcwald ◽  
Brendon Stubbs ◽  
...  
Keyword(s):  
Mental Illness ◽  
General Population ◽  
Severe Mental Illness ◽  
National Health ◽  
Health Survey ◽  
National Health Survey ◽  
Lifestyle Behaviors ◽  
Population Controls

scholarly journals A Systematic Review and Meta-Analysis on Mental Illness Symptoms in Spain in the COVID-19 Crisis

2021 ◽  
Author(s):  
Richard Z. Chen ◽  
Stephen X. Zhang ◽  
Wen Xu ◽  
Allen Yin ◽  
Rebecca Kechen Dong ◽  
...  
Keyword(s):  
Mental Illness ◽  
General Population ◽  
Adult Students ◽  
Meta Analysis ◽  
Total Sample ◽  
Future Research ◽  
Depression Symptoms ◽  
Prevalence Rates ◽  
Pooled Prevalence ◽  
Insomnia Symptoms

AbstractObjectiveThis paper systematically reviews and assesses the prevalence of anxiety, depression, and insomnia symptoms in the general population, frontline healthcare workers (HCWs), and adult students in Spain during the COVID-19 crisis.Data sourcesArticles in PubMed, Embase, Web of Science, PsycINFO, and medRxiv from March 2020 to February 6, 2021.ResultsThe pooled prevalence of anxiety symptoms in 23 studies comprising a total sample of 85,560 was 20% (95% CI: 15% - 25%, I2 = 99.9%), that of depression symptoms in 23 articles with a total sample comprising of 86,469 individuals was 23% (95% CI: 18% - 28%, I2 = 99.8%), and that of insomnia symptoms in 4 articles with a total sample of 915 were 52% (95% CI: 42-64%, I2 = 88.9%). The overall prevalence of mental illness symptoms in frontline HCWs, general population, and students in Spain are 42%, 19%, and 50%, respectively.DiscussionThe accumulative evidence from the meta-analysis reveals that adults in Spain suffered higher prevalence rates of mental illness symptoms during the COVID-19 crisis with a significantly higher rate relative to other countries such as China. Our synthesis reveals high heterogeneity, varying prevalence rates and a relative lack of studies in frontline and general HCWs in Spain, calling future research and interventions to pay attention to those gaps to help inform evidence-based mental health policymaking and practice in Spain during the continuing COVID-19 crisis. The high prevalence rates call for preventative and prioritization measures of the mental illness symptoms during the Covid-19 pandemic.

scholarly journals Attitudes surrounding the disclosure of mental illness

BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S288-S289
Author(s):  
Brishti Sengupta ◽  
Pritha Dasgupta
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
General Population ◽  
Online Survey ◽  
Mental Health Problems ◽  
Population Group ◽  
Medical Professionals ◽  
Health Issues ◽  
Mental Health Issues ◽  
Attitude Shift

AimsTo survey the effect of COVID-19 on mental health of both medical professionals and the general population, as well as attitudes surrounding the disclosure of mental illness.MethodAn online survey comprised of two questionnaires, one for medical professionals and one for the general population, were conducted via social media. Both questionnaires asked respondents of the effect of COVID-19 on their mental health, and the former asked respondents about the effect of COVID-19 on their patient group's mental health. The questionnaires went on to ask respondents about their attitudes to mental health disclosure in various scenarios, to varying groups of people. The general population group was also asked how they would react if someone else disclosed their mental illness to them.ResultThe questionnaire for the medical professionals gained 62 respondents and the one for the general population had 122 respondents, with responses from multiple nations. Overall, COVID-19 has affected everyone's mental health to a degree, and all groups had reservations about disclosing their mental health issues to others. The medical professionals were especially reluctant to disclose mental illness to their patients, but were more comfortable when it came to disclosing mental illness to colleagues. The general population, however, was much more reluctant to disclose mental health issues to their colleagues. The general population were, on the whole, willing to listen to and help anyone who came to them with mental health concerns. Both groups surveyed showed reluctance toward disclosure to the wider community.ConclusionCOVID-19 appears to significantly affect not only physical health, but mental health as well. There is at least some degree of stigma surrounding the disclosure of mental health issues. While most would be happy to help anyone who came to them with their mental health problems, there seems to be an attitude shift when people must contend with mental health issues of their own.

scholarly journals Review of smoking cessation treatments for people with mental illness

2008 ◽  
Vol 14 (3) ◽  
pp. 208-216 ◽  
Author(s):  
Jonathan Campion ◽  
Ken Checinski ◽  
Jo Nurse
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
Smoking Cessation ◽  
General Population ◽  
Antipsychotic Medication ◽  
Gold Standard ◽  
Standard Treatment ◽  
Mental Health Problems ◽  
Quit Smoking ◽  
People With Mental Illness

This article reviews the current literature regarding treatments for smoking cessation in both the general population and in those with mental health problems. The gold-standard treatment for the general population is pharmacotherapy (nicotine replacement therapy, bupropion or varenicline) coupled with individual or group psychological support. This is also effective in helping people with mental illness to reduce or quit smoking, but care must be taken to avoid adverse medication interactions and to monitor antipsychotic medication in particular as cigarette consumption reduces.

Resisting stigma and evaluating realism in a direct-to-consumer advertisement for psychiatric drugs

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Tara Walker
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
General Population ◽  
Online Survey ◽  
Bipolar Depression ◽  
Online Advertising ◽  
Sample Population ◽  
Content Type ◽  
Direct To Consumer ◽  
Psychiatric Drugs

Purpose This study aims to examine how experience with mental illness influences perceptions of stigma and realism in a specific direct-to-consumer advertisement (DTCA) for bipolar depression. Design/methodology/approach An online survey had participants watch a 90 s advertisement for a prescription bipolar depression drug and then answer 24 questions about stigma, mental illness experience and the realism of the portrayals in the advertisement. Findings Findings show that people who identify as having experience with mental illness tend to see the ad as more stigmatizing and less realistic. Additionally, people who expressed more stigmatizing beliefs also tended to see more stigma present in the ad. Finally, the study reconfirms conclusions of previous research that people who have experience with mental health conditions possess fewer stigmatizing beliefs overall regarding mental illness. Research limitations/implications The sample population, while diverse in age and somewhat diverse in location, were highly educated, suggesting that they were not representative of the general population. Future studies may want to use more representative samples. A more nuanced approach to understanding experience is needed. While the sample in this study was purposively derived from communities with a higher rate of mental illness, a comprehensive experience scale to measure degrees of experience with mental illness would enhance understanding of this construct. Researchers may also want to look more deeply into the emotional responses of consumers who view these ads. To develop a greater understanding of the trajectory of DTCA, studies of online advertising for psychiatric drugs are needed. Practical implications The results of the study suggest that respondents with experience with mental illness may find ads that sell psychiatric medications unrealistic. This study presents the topic of realism in DTCA as an important construct for determining how consumers may perceive portrayals of disorders. Social implications The fact that people who have experience with mental illness found the Latuda ad to be generally unrealistic suggests that DTCA may be failing to represent mental illness in a way that demonstrates care for patients. Additionally, this research confirms that people who have had exposure to and experience with mental illness tend to hold less stigmatizing beliefs, (Link and Cullen, 1986; Corrigan et al., 2001; Angermeyer et al., 2004) a finding which supports the continuing project of increasing mental health literacy and awareness in the general population. Originality/value This study investigates the reactions of people who identify as having some experience with mental illness to see if they accept the portrayals of mental illness in DTCA or resist them by challenging their realism or identifying stigmatizing elements.

Sign in / Sign up

Export Citation Format

Share Document